ID   MARC2_RAT               Reviewed;         338 AA.
AC   O88994;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   24-JUL-2024, entry version 108.
DE   RecName: Full=Mitochondrial amidoxime reducing component 2;
DE            Short=mARC2;
DE            EC=1.7.-.-;
DE   AltName: Full=Molybdenum cofactor sulfurase C-terminal domain-containing protein 2;
DE            Short=MOSC domain-containing protein 2;
DE            Short=Moco sulfurase C-terminal domain-containing protein 2;
DE   Flags: Precursor;
GN   Name=Mtarc2; Synonyms=Marc2, Mg87, Mosc2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=GK; TISSUE=Kidney;
RA   Page R.A.;
RT   "Isolation of a novel gene, MG87, from the diabetic kidney.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the reduction of N-oxygenated molecules, acting as
CC       a counterpart of cytochrome P450 and flavin-containing monooxygenases
CC       in metabolic cycles. As a component of prodrug-converting system,
CC       reduces a multitude of N-hydroxylated prodrugs particularly amidoximes,
CC       leading to increased drug bioavailability. May be involved in
CC       mitochondrial N(omega)-hydroxy-L-arginine (NOHA) reduction, regulating
CC       endogenous nitric oxide levels and biosynthesis. Postulated to cleave
CC       the N-OH bond of N-hydroxylated substrates in concert with electron
CC       transfer from NADH to cytochrome b5 reductase then to cytochrome b5,
CC       the ultimate electron donor that primes the active site for substrate
CC       reduction. {ECO:0000250|UniProtKB:Q969Z3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 Fe(II)-[cytochrome b5] + 2 H(+) + N(omega)-hydroxy-L-
CC         arginine = 2 Fe(III)-[cytochrome b5] + H2O + L-arginine;
CC         Xref=Rhea:RHEA:61644, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:29033,
CC         ChEBI:CHEBI:29034, ChEBI:CHEBI:32682, ChEBI:CHEBI:60107;
CC         Evidence={ECO:0000250|UniProtKB:Q969Z3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61645;
CC         Evidence={ECO:0000250|UniProtKB:Q969Z3};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302; Evidence={ECO:0000250};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250};
CC   -!- SUBUNIT: Component of a complex composed of cytochrome b5, NADH-
CC       cytochrome b5 reductase (CYB5R3) and MTARC2. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Peroxisome {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by PRKN during mitophagy, leading to its degradation
CC       and enhancement of mitophagy. Deubiquitinated by USP30.
CC       {ECO:0000250|UniProtKB:Q969Z3}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF095741; AAC64190.1; -; mRNA.
DR   EMBL; BC061734; AAH61734.1; -; mRNA.
DR   RefSeq; NP_599237.1; NM_134410.2.
DR   AlphaFoldDB; O88994; -.
DR   SMR; O88994; -.
DR   STRING; 10116.ENSRNOP00000034963; -.
DR   iPTMnet; O88994; -.
DR   PhosphoSitePlus; O88994; -.
DR   SwissPalm; O88994; -.
DR   jPOST; O88994; -.
DR   PaxDb; 10116-ENSRNOP00000034963; -.
DR   Ensembl; ENSRNOT00060011396; ENSRNOP00060008520; ENSRNOG00060006953.
DR   Ensembl; ENSRNOT00065028650; ENSRNOP00065022697; ENSRNOG00065017179.
DR   GeneID; 171451; -.
DR   KEGG; rno:171451; -.
DR   UCSC; RGD:621257; rat.
DR   AGR; RGD:621257; -.
DR   CTD; 54996; -.
DR   RGD; 621257; Mtarc2.
DR   eggNOG; KOG2362; Eukaryota.
DR   InParanoid; O88994; -.
DR   OrthoDB; 5490564at2759; -.
DR   PhylomeDB; O88994; -.
DR   Reactome; R-RNO-211945; Phase I - Functionalization of compounds.
DR   PRO; PR:O88994; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IEA:UniProtKB-SubCell.
DR   GO; GO:0030151; F:molybdenum ion binding; ISO:RGD.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; ISO:RGD.
DR   GO; GO:0008940; F:nitrate reductase activity; ISO:RGD.
DR   GO; GO:0098809; F:nitrite reductase activity; ISO:RGD.
DR   GO; GO:0016661; F:oxidoreductase activity, acting on other nitrogenous compounds as donors; ISO:RGD.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0070458; P:cellular detoxification of nitrogen compound; ISO:RGD.
DR   GO; GO:0042126; P:nitrate metabolic process; ISO:RGD.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; ISO:RGD.
DR   InterPro; IPR005302; MoCF_Sase_C.
DR   InterPro; IPR005303; MOCOS_middle.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom_sf.
DR   PANTHER; PTHR14237:SF27; MITOCHONDRIAL AMIDOXIME REDUCING COMPONENT 2; 1.
DR   PANTHER; PTHR14237; MOLYBDOPTERIN COFACTOR SULFURASE MOSC; 1.
DR   Pfam; PF03473; MOSC; 1.
DR   Pfam; PF03476; MOSC_N; 1.
DR   SUPFAM; SSF141673; MOSC N-terminal domain-like; 1.
DR   SUPFAM; SSF50800; PK beta-barrel domain-like; 1.
DR   PROSITE; PS51340; MOSC; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Isopeptide bond; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Molybdenum; Oxidoreductase; Peroxisome;
KW   Reference proteome; Transit peptide; Ubl conjugation.
FT   TRANSIT         1..35
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           36..338
FT                   /note="Mitochondrial amidoxime reducing component 2"
FT                   /id="PRO_0000273344"
FT   DOMAIN          188..336
FT                   /note="MOSC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00670"
FT   MOD_RES         156
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q922Q1"
FT   CROSSLNK        59
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        138
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        144
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        156
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        173
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        187
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        289
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
FT   CROSSLNK        296
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q969Z3"
SQ   SEQUENCE   338 AA;  38248 MW;  2FF2E1AFEFF8F7C6 CRC64;
     MGSSSSTALA RLGLPGQPRS TWLGVAALGL AAVALGTVAW RRARPRRRRQ LQQVGTVSKV
     WIYPIKSCKG VSVCETECTD MGLRCGKVRD RFWMVVKEDG HMITARQEPR LVLVTITLEN
     NYLMLEAPGM EPIVLPIKLP SSNKIHDCRL FGLDIKGRDC GDEVARWFTS YLKTQAYRLV
     QFDTKMKGRT TKKLYPSESY LQNYEVAYPD CSPIHLISEA SLVDLNTRLQ KKVKMEYFRP
     NIVVSGCEAF EEDTWDELLI GDVEMKRVLS CPRCVLTTVD PDTGIIDRKE PLETLKSYRL
     CDPSVKSLYQ SSPLFGMYFS VEKIGSLRVG DPVYRMVD
//
